H L Grierson

460 citations
9 papers · 376 indexed · h-index 7

H L Grierson

9 papers receiving 353 citations

Peers

H L Grierson
Comparison fields: 5 of 53
  • Hematology 144
  • Infectious Diseases 135
  • Oncology 186
  • Immunology 104
  • Pathology and Forensic Medicine 83
Replace Robert Harper with:
Robert Harper United States
R Hanada Japan
R. Champlin United States
H E Heslop United States
Kirsten Huck Germany
Wolfgang Hill Germany
Ikuo Miura Japan
P. Coccia United States
Goldman Jm United Kingdom
G. A. M. de Vaan Netherlands
H L Grierson relative to Robert Harper United States Robert Harper's profile →
Citations per field
00.5×
Robert Harper · 1×
Citations per year

Countries citing papers authored by H L Grierson

Since Specialization
Citations

This map shows the geographic impact of H L Grierson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H L Grierson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H L Grierson more than expected).

Fields of papers citing papers by H L Grierson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H L Grierson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H L Grierson. The network helps show where H L Grierson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside H L Grierson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with H L Grierson Line = papers co-authored together H L Grierson links everyone, so they are left out of the graph.

All Works

9 of 9 papers shown
#Work
1 19953
2 19925
3 199013
4 19897
5 198930
6
Virus-associated histiocytic proliferations in children. Frequent association with Epstein-Barr virus and congenital or acquired immunodeficiencies.
198884
7 1988160
8 19888
9
Acute leukemia expressing the normal human hematopoietic stem cell membrane glycoprotein CD34 (MY10).
198866

About H L Grierson

H L Grierson is a scholar working on Physiology, Oncology and Infectious Diseases, having authored 9 papers that have together received 376 indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (5 papers), Parvovirus B19 Infection Studies (4 papers), Lymphoma Diagnosis and Treatment (3 papers), Cytomegalovirus and herpesvirus research (2 papers), Immune Cell Function and Interaction (2 papers), Vascular Tumors and Angiosarcomas (1 paper), Adenosine and Purinergic Signaling (1 paper) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Hematology (144 citations), Infectious Diseases (135 citations) and Oncology (186 citations). H L Grierson has collaborated with scholars based in United States and Australia. Frequent co-authors include David T. Purtilo, Motohiko Okano, Jack R. Davis, Kenneth L. McClain, Richard C. Gehrz, A. H. Filipovich, Warren G. Sanger, CI Civin, DD Weisenburger and Judith E. Karp. Their work appears in journals such as Clinical Microbiology Reviews, Environmental Health Perspectives and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026